A new way to help CAR T cells last longer against a childhood cancer
Original title: FECH, a novel metabolic target influencing CAR T-cell phenotype and function.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in lab cells and animals, not in people.
The short version
Lab tests found a way to keep CAR T cells stronger for longer.
What was studied. CAR T cells are immune cells changed in a lab to fight cancer. Researchers tested them on neuroblastoma, a cancer in children, and added a drug called linsitinib. They also blocked an enzyme called FECH.
What they found. The drug plus CAR T cells killed more cancer cells in the lab. The drug and the FECH block both lowered heme inside the T cells. The T cells then looked less worn out and acted more like long lasting memory cells.
What this means, and what it doesn't
What it could mean: This points to a new way to make CAR T cells work longer. It may help researchers build better versions of this treatment later. It does not change care that is offered today.
What it doesn't mean: This work was done in lab cells and in animals, not in people. It is not a treatment anyone can ask for now. It is not proof that this will help patients, and it is not a cure.
Source: PubMed, August 12, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.